Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Sales | 2,934 | 0 | 0 |
| Gross Profit | 2,934 | N/A | N/A |
| Operating Expenses | 45,139 | 0 | 0 |
| Operating Income | -42,205 | N/A | N/A |
| Interest Expense | 46 | 0 | 0 |
| Other Income | 1,005 | 0 | 0 |
| Pre-tax Income | -41,246 | 0 | 0 |
| Net Income Continuous | -41,246 | N/A | N/A |
| Net Income | $-41,246 | $N/A | $N/A |
| EPS Basic Total Ops | -24.28 | N/A | N/A |
| EPS Basic Continuous Ops | -24.28 | N/A | N/A |
| EPS Diluted Total Ops | -24.28 | N/A | N/A |
| EPS Diluted Continuous Ops | -24.28 | N/A | N/A |
| EBITDA(a) | $-41,380 | $N/A | $N/A |